Detalhe da pesquisa
1.
Neutrophil to lymphocyte ratio in myelofibrosis patients treated with ruxolitinib may predict prognosis and rate of discontinuation.
Eur J Haematol
; 112(6): 938-943, 2024 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-38332702
2.
Systemic mastocytosis: 2023 update on diagnosis and management in adults.
Expert Opin Emerg Drugs
; 28(3): 153-165, 2023 12.
Artigo
Inglês
| MEDLINE | ID: mdl-37256917
3.
Deferasirox in the management of iron overload in patients with myelofibrosis treated with ruxolitinib: The multicentre retrospective RUX-IOL study.
Br J Haematol
; 197(2): 190-200, 2022 04.
Artigo
Inglês
| MEDLINE | ID: mdl-35137397
4.
Utility of procalcitonin and C-reactive protein as predictors of Gram-negative bacteremia in febrile hematological outpatients.
Support Care Cancer
; 30(5): 4303-4314, 2022 May.
Artigo
Inglês
| MEDLINE | ID: mdl-35088150
5.
Impact of comorbidities and body mass index on the outcome of polycythemia vera patients.
Hematol Oncol
; 39(3): 409-418, 2021 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-33590502
6.
Real-life comparison of nilotinib versus dasatinib as second-line therapy in chronic phase chronic myeloid leukemia patients.
Ann Hematol
; 100(5): 1213-1219, 2021 May.
Artigo
Inglês
| MEDLINE | ID: mdl-33677654
7.
Acute promyelocytic leukemia (APL) in very old patients: real-life behind protocols.
Acta Oncol
; 60(11): 1520-1526, 2021 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-34461798
8.
Long term follow-up of frontline Dasatinib in older patients with chronic myeloid leukemia in chronic phase treated outside clinical trials: a real-life cohort observational study.
Acta Oncol
; 60(11): 1527-1533, 2021 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-34499575
9.
Pulmonary infections in patients with myelodysplastic syndromes receiving frontline azacytidine treatment.
Hematol Oncol
; 38(2): 189-196, 2020 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-31891213
10.
Erythropoietin treatment in chronic phase chronic myeloid leukemia patients treated with frontline imatinib who developed late anemia.
Eur J Haematol
; 105(3): 286-291, 2020 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-32365249
11.
Treatment of Philadelphia-negative myeloproliferative neoplasms in accelerated/blastic phase with azacytidine. Clinical results and identification of prognostic factors.
Hematol Oncol
; 37(3): 291-295, 2019 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-31050810
12.
Early death risk score in acute promyelocytic leukemia: A retrospective analysis from a monocentric cohort.
Eur J Haematol
; 112(4): 654-657, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38093665
13.
Nonmelanoma skin cancer associated with Hydroxyurea treatment: Overview of the literature and our own experience.
Dermatol Ther
; 32(5): e13043, 2019 09.
Artigo
Inglês
| MEDLINE | ID: mdl-31364787
14.
One-month qRT-PCR BCR::ABL1 transcript threshold to predict early recurrence in chronic phase CML patients attempting first treatment free remission.
Eur J Haematol
; 111(6): 970-972, 2023 12.
Artigo
Inglês
| MEDLINE | ID: mdl-37587772
15.
Clinical results according to age in patients with chronic myeloid leukemia receiving imatinib frontline: The younger, the later, the worse?
Eur J Haematol
; 2018 Jun 13.
Artigo
Inglês
| MEDLINE | ID: mdl-29896890
16.
Impact of exclusion criteria for the DASISION and ENESTnd trials in the front-line treatment of a 'real-life' patient population with chronic myeloid leukaemia.
Hematol Oncol
; 35(2): 232-236, 2017 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-26648184
17.
Real-life use of erythropoiesis-stimulating agents in myelodysplastic syndromes: a "Gruppo Romano Mielodisplasie (GROM)" multicenter study.
Ann Hematol
; 95(7): 1059-65, 2016 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-27091349
18.
Lenalidomide for myelodysplastic syndromes with del(5q): how long should it last?
Hematol Oncol
; 33(1): 48-51, 2015 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-25950027
19.
Acute promyelocytic leukemia in patients aged >70 years: the cure beyond the age.
Ann Hematol
; 94(2): 195-200, 2015 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-25186786
20.
Incidence of persistent/late chronic anemia in newly diagnosed patients with chronic myeloid leukemia responsive to imatinib.
Am J Hematol
; 90(2): 105-8, 2015 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-25349084